174 related articles for article (PubMed ID: 23506958)
1. Modeling solid-state transformations occurring in dissolution testing.
Laaksonen T; Aaltonen J
Int J Pharm; 2013 Apr; 447(1-2):218-23. PubMed ID: 23506958
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous measurement of liquid-phase and solid-phase transformation kinetics in rotating disc and channel flow cell dissolution devices.
Lehto P; Aaltonen J; Niemelä P; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
Int J Pharm; 2008 Nov; 363(1-2):66-72. PubMed ID: 18675891
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
4. Chemical imaging of oral solid dosage forms and changes upon dissolution using coherent anti-Stokes Raman scattering microscopy.
Windbergs M; Jurna M; Offerhaus HL; Herek JL; Kleinebudde P; Strachan CJ
Anal Chem; 2009 Mar; 81(6):2085-91. PubMed ID: 19209888
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the aqueous dissolution of semicrystalline poly(ethylene oxide) using infrared chemical imaging: the effects of molecular weight and crystallinity.
Coutts-Lendon C; Koenig JL
Appl Spectrosc; 2005 Aug; 59(8):976-85. PubMed ID: 16105205
[TBL] [Abstract][Full Text] [Related]
6. Applications of supercritical fluids to enhance the dissolution behaviors of Furosemide by generation of microparticles and solid dispersions.
De Zordi N; Moneghini M; Kikic I; Grassi M; Del Rio Castillo AE; Solinas D; Bolger MB
Eur J Pharm Biopharm; 2012 May; 81(1):131-41. PubMed ID: 22266263
[TBL] [Abstract][Full Text] [Related]
7. In situ dissolution analysis using coherent anti-Stokes Raman scattering (CARS) and hyperspectral CARS microscopy.
Fussell A; Garbacik E; Offerhaus H; Kleinebudde P; Strachan C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1141-7. PubMed ID: 23994672
[TBL] [Abstract][Full Text] [Related]
8. Phase transformation considerations during process development and manufacture of solid oral dosage forms.
Zhang GG; Law D; Schmitt EA; Qiu Y
Adv Drug Deliv Rev; 2004 Feb; 56(3):371-90. PubMed ID: 14962587
[TBL] [Abstract][Full Text] [Related]
9. Analysis of solid-state transformations of pharmaceutical compounds using vibrational spectroscopy.
Heinz A; Strachan CJ; Gordon KC; Rades T
J Pharm Pharmacol; 2009 Aug; 61(8):971-88. PubMed ID: 19703341
[TBL] [Abstract][Full Text] [Related]
10. Solution-mediated phase transformation: significance during dissolution and implications for bioavailability.
Greco K; Bogner R
J Pharm Sci; 2012 Sep; 101(9):2996-3018. PubMed ID: 22213419
[TBL] [Abstract][Full Text] [Related]
11. Improvement of the dissolution rate of poorly soluble drugs by solid crystal suspensions.
Thommes M; Ely DR; Carvajal MT; Pinal R
Mol Pharm; 2011 Jun; 8(3):727-35. PubMed ID: 21344937
[TBL] [Abstract][Full Text] [Related]
12. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
13. Solvent-mediated solid phase transformations of carbamazepine: Effects of simulated intestinal fluid and fasted state simulated intestinal fluid.
Lehto P; Aaltonen J; Tenho M; Rantanen J; Hirvonen J; Tanninen VP; Peltonen L
J Pharm Sci; 2009 Mar; 98(3):985-96. PubMed ID: 18661533
[TBL] [Abstract][Full Text] [Related]
14. In situ measurement of solvent-mediated phase transformations during dissolution testing.
Aaltonen J; Heinänen P; Peltonen L; Kortejärvi H; Tanninen VP; Christiansen L; Hirvonen J; Yliruusi J; Rantanen J
J Pharm Sci; 2006 Dec; 95(12):2730-7. PubMed ID: 16892206
[TBL] [Abstract][Full Text] [Related]
15. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
Blagden N; de Matas M; Gavan PT; York P
Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous UV imaging and raman spectroscopy for the measurement of solvent-mediated phase transformations during dissolution testing.
Østergaard J; Wu JX; Naelapää K; Boetker JP; Jensen H; Rantanen J
J Pharm Sci; 2014 Apr; 103(4):1149-56. PubMed ID: 24496995
[TBL] [Abstract][Full Text] [Related]
17. Mathematical modeling of drug dissolution.
Siepmann J; Siepmann F
Int J Pharm; 2013 Aug; 453(1):12-24. PubMed ID: 23618956
[TBL] [Abstract][Full Text] [Related]
18. Extension of the dissolution-precipitation model for kinetic elucidation of solvent-mediated polymorphic transformations.
Jakubiak P; Schuler F; Alvarez-Sánchez R
Eur J Pharm Biopharm; 2016 Dec; 109():43-48. PubMed ID: 27648958
[TBL] [Abstract][Full Text] [Related]
19. Modeling accelerated and decelerated drug release in terms of fractional release rate.
Weiss M
Eur J Pharm Sci; 2015 Feb; 68():51-5. PubMed ID: 25486334
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the causes of cocrystal dissociation at high humidity.
Eddleston MD; Thakuria R; Aldous BJ; Jones W
J Pharm Sci; 2014 Sep; 103(9):2859-2864. PubMed ID: 24481664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
